THC

Tenet Healthcare Corp. 10-Q Summary (Period Ended June 30, 2003)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2003, and the six-month period ended on that date. Tenet Healthcare Corporation operates a network of general hospitals and related health care businesses. The company recently changed its fiscal year to coincide with the calendar year, effective December 31, 2002. Management is navigating a challenging transitional period characterized by lower revenue trends due to changes in Medicare outlier payment calculations and increasing cost pressures from labor shortages and malpractice expenses.

Key Financial Metrics

Per Share Data (Six Months 2003): Basic and Diluted Net Loss per share was $(0.46). Income from continuing operations was a loss of $(0.24) per share.

Material Changes vs. Prior Period

• Profitability: The company reported a net loss of $215 million for the six months ended June 30, 2003, compared to net income of $520 million in the same period in 2002. This reversal is primarily due to significant non-recurring charges.
• Unusual Charges: The 2003 period included $385 million in impairment of goodwill and long-lived assets, $86 million in restructuring charges, and $74 million in litigation and investigation costs. In contrast, the 2002 period included $102 million in losses from early extinguishment of debt and $40 million in goodwill amortization.
• Revenue Trends: Net operating revenues increased slightly by $26 million (0.4%) year-over-year. However, on a same-facility basis, net inpatient revenue per admission decreased by 4.6% due to the voluntary adoption of a new method for calculating Medicare outlier payments, which reduced outlier revenue from approximately $65 million per month to $6 million per month.
• Discontinued Operations: The company announced a plan to dispose of or consolidate 14 general hospitals. These assets are classified as held for sale ($565 million). Discontinued operations resulted in a net loss of $101 million for the six-month period.

Guidance, Outlook, and Risks

Outlook: Management expects the transitional period to continue through at least the first half of 2004. Earnings per share from continuing operations for the third and fourth quarters of fiscal 2003 are expected to total between $0.40 and $0.50. For the 12 months from July 1, 2003, through June 30, 2004, EPS is expected to be between $0.80 and $1.00. This guidance excludes future impairment, restructuring, and litigation costs.

Strategic Initiatives: The company is implementing cost reduction plans targeting $100 million in annual savings by year-end 2003 and an additional $100 million by the end of 2004. These include staff reductions, supply chain improvements, and consolidation of business offices.

Risks and Contingencies:

• Legal Proceedings: The company faces significant investigations regarding physician relationships, Medicare outlier payments, and pricing practices. A $54 million settlement was reached in August 2003 regarding the Redding Medical Center matter. The SEC has issued a subpoena for a formal investigation.
• Government Programs: Changes in Medicare and Medicaid reimbursement rates and formulas pose a material risk. The company voluntarily adopted a new method for calculating Medicare outlier payments, significantly reducing revenue from this source.
• Liquidity: While the company has $1.3 billion in available credit under its revolving credit agreement and a leverage ratio of 1.82-to-1 (well below the 2.5-to-1 covenant limit), future cash flows are under pressure from lower revenues and high legal costs.

Investor Verification Checklist

• Verify the final terms and potential future liabilities of the $54 million Redding Medical Center settlement and other pending litigation.
• Monitor the outcome of the SEC investigation and the Department of Justice's review of Medicare outlier billing practices.
• Assess the progress of the divestiture of the 14 hospitals classified as discontinued operations and the realization of expected proceeds.
• Track the implementation of cost-cutting measures and their impact on operating margins in upcoming quarters.
• Review the impact of the new Medicare outlier payment methodology on future revenue stability and the potential for reconciliation adjustments.